---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-053328"
form_type: "8-K"
ticker: "AGL"
cik: "0001831097"
company_name: "agilon health, inc."
filed_at: "2026-08-05T20:07:17+00:00"
generated_at: "2026-08-05T20:08:24.404056+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# agilon health Q2 net income $18M vs loss; raises FY2026 guidance

## Summary
- Total revenue $1.49B (+7% YoY); net income $18M vs net loss $104M in Q2 2025.
- Medical margin $197M vs negative $53M; Adjusted EBITDA $70M vs negative $83M.
- Total members 549,000 (down 10% YoY) due to disciplined contracting and market exits.
- FY2026 guidance raised: revenue $5,775-$5,860M, medical margin $465-$505M, Adj. EBITDA $75-$95M.
- Q3 2026 guidance: revenue $1,445-$1,475M, medical margin $105-$115M, Adj. EBITDA ($5)-$5M.

## SEC filing metadata
- accession: 0001628280-26-053328
- form_type: 8-K
- ticker: AGL
- cik: 0001831097
- company_name: agilon health, inc.
- filed_at: 2026-08-05T20:07:17+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831097/000162828026053328/0001628280-26-053328-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831097/000162828026053328/agl-20260805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-053328
- JSON: https://secwatch.observer/filing/0001628280-26-053328.json
- Plain text: https://secwatch.observer/filing/0001628280-26-053328.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.